Favezelimab (anti-LAG3)
|
Ab190152-10mg
|
ExactAb?, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot |
2231068-83-8 |
10mg
|
¥ 12159.9
|
期貨,請咨詢 |
阿拉丁 |
Naptumomab (anti-TPBG)
|
Ab190149-5mg
|
無載體, 重組, ExactAb?, 低內(nèi)毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
676258-98-3 |
5mg
|
¥ 7129.9
|
期貨,請咨詢 |
阿拉丁 |
Naptumomab (anti-TPBG)
|
Ab190149-1mg
|
無載體, 重組, ExactAb?, 低內(nèi)毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
676258-98-3 |
1mg
|
¥ 2859.9
|
期貨,請咨詢 |
阿拉丁 |
Naptumomab (anti-TPBG)
|
Ab190149-10mg
|
無載體, 重組, ExactAb?, 低內(nèi)毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
676258-98-3 |
10mg
|
¥ 11409.9
|
期貨,請咨詢 |
阿拉丁 |
Naptumomab (anti-TPBG)
|
Ab190149-100μg
|
無載體, 重組, ExactAb?, 低內(nèi)毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
676258-98-3 |
100μg
|
¥ 579.9
|
期貨,請咨詢 |
阿拉丁 |
Iparomlimab (anti-PDCD1)
|
Ab190143-5mg
|
無載體, 重組, ExactAb?, 低內(nèi)毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2417649-33-1 |
5mg
|
¥ 9999.9
|
期貨,請咨詢 |
阿拉丁 |
Iparomlimab (anti-PDCD1)
|
Ab190143-1mg
|
無載體, 重組, ExactAb?, 低內(nèi)毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2417649-33-1 |
1mg
|
¥ 3319.9
|
期貨,請咨詢 |
阿拉丁 |
Iparomlimab (anti-PDCD1)
|
Ab190143-10mg
|
無載體, 重組, ExactAb?, 低內(nèi)毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2417649-33-1 |
10mg
|
¥ 15999.9
|
期貨,請咨詢 |
阿拉丁 |
Iparomlimab (anti-PDCD1)
|
Ab190143-100μg
|
無載體, 重組, ExactAb?, 低內(nèi)毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2417649-33-1 |
100μg
|
¥ 669.9
|
期貨,請咨詢 |
阿拉丁 |
RG-6125 (anti-Cadherin-11)
|
Ab190140-5mg
|
無載體, 重組, ExactAb?, 低內(nèi)毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
5mg
|
¥ 9999.9
|
期貨,請咨詢 |
阿拉丁 |
RG-6125 (anti-Cadherin-11)
|
Ab190140-1mg
|
無載體, 重組, ExactAb?, 低內(nèi)毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
1mg
|
¥ 1999.9
|
期貨,請咨詢 |
阿拉丁 |
RG-6125 (anti-Cadherin-11)
|
Ab190140-10mg
|
無載體, 重組, ExactAb?, 低內(nèi)毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
10mg
|
¥ 15999.9
|
期貨,請咨詢 |
阿拉丁 |
RG-6125 (anti-Cadherin-11)
|
Ab190140-100μg
|
無載體, 重組, ExactAb?, 低內(nèi)毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
100μg
|
¥ 669.9
|
期貨,請咨詢 |
阿拉丁 |
TAK-701 (anti-HGF)
|
Ab190138-5mg
|
無載體, 重組, ExactAb?, 低內(nèi)毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
5mg
|
¥ 9999.9
|
期貨,請咨詢 |
阿拉丁 |
TAK-701 (anti-HGF)
|
Ab190138-1mg
|
無載體, 重組, ExactAb?, 低內(nèi)毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
1mg
|
¥ 3319.9
|
期貨,請咨詢 |
阿拉丁 |
TAK-701 (anti-HGF)
|
Ab190138-10mg
|
無載體, 重組, ExactAb?, 低內(nèi)毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
10mg
|
¥ 15999.9
|
期貨,請咨詢 |
阿拉丁 |
TAK-701 (anti-HGF)
|
Ab190138-100μg
|
無載體, 重組, ExactAb?, 低內(nèi)毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
100μg
|
¥ 669.9
|
期貨,請咨詢 |
阿拉丁 |
ICT-01 (anti-BTN1A1)
|
Ab190124-5mg
|
無載體, 生物活性, 重組, ExactAb?, 低內(nèi)毒素, 無疊氮鈉, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
5mg
|
¥ 9999.9
|
期貨,請咨詢 |
阿拉丁 |
ICT-01 (anti-BTN1A1)
|
Ab190124-1mg
|
無載體, 生物活性, 重組, ExactAb?, 低內(nèi)毒素, 無疊氮鈉, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
1mg
|
¥ 3319.9
|
期貨,請咨詢 |
阿拉丁 |
ICT-01 (anti-BTN1A1)
|
Ab190124-10mg
|
無載體, 生物活性, 重組, ExactAb?, 低內(nèi)毒素, 無疊氮鈉, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
10mg
|
¥ 15999.9
|
期貨,請咨詢 |
阿拉丁 |
ICT-01 (anti-BTN1A1)
|
Ab190124-100μg
|
無載體, 生物活性, 重組, ExactAb?, 低內(nèi)毒素, 無疊氮鈉, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
100μg
|
¥ 669.9
|
期貨,請咨詢 |
阿拉丁 |
Enapotamab vedotin (anti-Axl)
|
Ab183333-5mg
|
ExactAb?, 重組, 已驗證, 無疊氮鈉, 低內(nèi)毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot |
1912424-97-5 |
5mg
|
¥ 18879.9
|
期貨,請咨詢 |
阿拉丁 |
Enapotamab vedotin (anti-Axl)
|
Ab183333-1mg
|
ExactAb?, 重組, 已驗證, 無疊氮鈉, 低內(nèi)毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot |
1912424-97-5 |
1mg
|
¥ 7549.9
|
期貨,請咨詢 |
阿拉丁 |
Enapotamab vedotin (anti-Axl)
|
Ab183333-10mg
|
ExactAb?, 重組, 已驗證, 無疊氮鈉, 低內(nèi)毒素, 無載體, ≥90%(SDS-PAGE&SEC), Lot by Lot |
1912424-97-5 |
10mg
|
¥ 30299.9
|
期貨,請咨詢 |
阿拉丁 |